Identity
- Trade Name
- T.Cell Xtend® FDA UDI
- Generic Name
- Cell centrifugation/density gradient separation reagent IVD FDA UDI
- Device Name
- Approval for the use of t-cell xtend reagent with the t-spot. Tb test, in order to extend the time from sample collection to sample processing from within 8 hours of venepuncture to between 23 and 30 hours post venepuncture; and to make a technical correction to the t-spot. Tb test package insert to change the number of blood collection tubes required from (2) 6 ml heparin tubes to (1) 6 ml heparin tube. The t-cell xtend reagent is indicated for use with the t-spot. Tb test for the pre-treatment of whole blood prior to lymphocyte separation. The reagent aids in the removal of selected white blood cells from whole blood stored at room temperature (18-25 degrees c). FDA UDI
- Model / Reference
- TTK.610 FDA UDI
- Description
- Approval for the use of t-cell xtend reagent with the t-spot. Tb test, in order to extend the time from sample collection to sample processing from within 8 hours of venepuncture to between 23 and 30 hours post venepuncture; and to make a technical correction to the t-spot. Tb test package insert to change the number of blood collection tubes required from (2) 6 ml heparin tubes to (1) 6 ml heparin tube. The t-cell xtend reagent is indicated for use with the t-spot. Tb test for the pre-treatment of whole blood prior to lymphocyte separation. The reagent aids in the removal of selected white blood cells from whole blood stored at room temperature (18-25 degrees c). FDA UDI
Identifiers
- Catalog Number
- TTK.610US FDA UDI
- Primary DI / UDI-DI
- 15051716000022 FDA UDI
- PMA Number
- P070006 FDA UDI
- FDA Product Code
- OJN FDA UDI
- GMDN Term
- Cell centrifugation/density gradient separation reagent IVD FDA UDI
Classification
- Device Class
- Class III FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Cell centrifugation/density gradient separation reagent IVD
T.Cell Xtend® by Oxford Immunotec, Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Cell centrifugation/density gradient separation reagent IVD.
- GM501 Gradient 90% — HAMILTON THORNE, Inc. · Class II
- Lympho-Kwik T Lymphocyte, 50 isolations — ONE LAMBDA, INC. · Class I
- GM501 Gradient 90% — HAMILTON THORNE, Inc. · Class II
- GM501 Gradient 100% — HAMILTON THORNE, Inc. · Class II
- FluoroBeads™ T Developer (10X) — ONE LAMBDA, INC. · Class I
- Lympholyte-H — Cedarlane Corporation · Class I
- Lympho-Kwik Mononuclear Cell, 50 isolations — ONE LAMBDA, INC. · Class I
- GM501 Gradient 90% — HAMILTON THORNE, Inc. · Class II
Cleared under the same submission
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class III | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Oxford Immunotec, Inc.
Sources (1)
- FDA UDI 60c1d520-5387-412e-bb88-35aea82359e0 36 fields · synced May 31, 2026